BPC-157 Chemical Structure: A Plain Look at the 15-Residue Sequence

A peptide is just a short protein - a handful of amino acids strung together in a fixed order. BPC-157 is one of the shortest such molecules to earn its own name, built from exactly fifteen of those building blocks. One thing has to be clear before we go further: BPC-157 is a chemical sold for research use only, not a product meant for human or animal consumption. With that framing in place, the most honest way to understand what BPC-157 actually is - no hype, no outcome promises - is to look at its chemistry. So that's what this article does, in plain language. We'll read the sequence one residue at a time, decode the molecular formula and the registry identifiers chemists use to pin it down, unpack the proline-rich motif that shapes it, trace where the sequence came from, and end on the curious gap between its structure and its stability.

The 15-Residue Sequence, Read Left to Right

Here is the molecule in full, written the way chemists write it. BPC-157 is a pentadecapeptide. "Pentadeca" is simply Greek for fifteen, so the word means a peptide of fifteen amino acids - nothing more exotic than that. Each amino acid, once locked into the chain, is called a residue, because part of its structure is shed when it bonds to its neighbour. In order, the fifteen residues are:

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

That string is the molecule's primary structure: the exact identity and order of its parts. Every three-letter code stands for one amino acid - Gly for glycine, Glu for glutamic acid, Pro for proline, and so on down the line. Peptide chains also have direction. By convention you read the sequence from the N-terminus (the end with a free amino group, here glycine) to the C-terminus (the end with a free carboxyl group, here valine). The bonds between residues are peptide bonds, and the order of those bonds is what makes the molecule what it is. Swap a single residue and you've got a different peptide. This exact sequence is the one logged in the peer-reviewed literature and in public chemical databases (Jelovac et al., European Journal of Pharmacology, 1999) and summarised in the public structural record for BPC-157.

How to read a sequence like this

New to sequences? Think of each three-letter code as a single bead, and the whole string as a bracelet threaded in one fixed direction. Nothing branches, nothing is ambiguous: fifteen beads, one order, one direction. That plainness is exactly why a short sequence can be spelled out on a single line and then reproduced precisely on a bench.

Reading the Molecular Formula and Identifiers

The sequence tells you the parts. The molecular formula tells you the raw atom count. For BPC-157 that formula is C₆₂H₉₈N₁₆O₂₂, which comes out to a molar mass of roughly 1,419.6 g/mol. By peptide standards that's small - plenty of signalling peptides and proteins run several times larger - and that modest size is part of why the molecule is straightforward to synthesise and characterise.

Casual names are slippery, so chemists lean on registry identifiers that point to one structure and nothing else. BPC-157 carries a full set. There's the CAS number 137525-51-0, the PubChem CID 9941957, the InChIKey HEEWEZGQMLZMFE-RKGINYAYSA-N, plus entries in DrugBank, ChEMBL, and the UNII system. An InChIKey is especially handy: it's a compact fingerprint generated from the full structure, so two researchers on opposite sides of the world can confirm they mean the identical molecule. All of these, along with the formula, sit in the consolidated structural record. And for anyone moving from the data sheet to the bench, our guide to how researchers dissolve peptides for lab work covers the practical side of handling a defined peptide like this one.

Why the Proline-Rich Backbone Matters

Look back at the sequence and one feature jumps out: prolines, and a lot of them. Three sit back to back at positions three, four, and five. A fourth lands at position eight. There's also a pair of adjacent aspartates (Asp-Asp) at positions ten and eleven. That proline density is unusual, and it's worth dwelling on, because proline is the odd one out among the twenty standard amino acids.

Most amino acids leave the backbone free to swivel. Proline doesn't. Its side chain loops back and bonds to its own backbone nitrogen, forming a ring that locks part of the chain into a fixed kink - picture a rigid elbow dropped into an otherwise flexible chain. A backbone studded with prolines can't fold into the neat, compact shapes that larger globular proteins adopt; it tends to stay relatively open and extended instead. In cell-culture and biochemical studies, researchers find this proline-rich, conformationally constrained design interesting precisely because shape and stability travel together - a theme we dig into in our piece on what a peptide's shape tells you about its function. The point here is structural, not clinical: the prolines are what give BPC-157 its characteristic backbone geometry.

Where the Sequence Comes From

BPC-157 didn't start life on a synthesiser. The "BPC" stands for Body Protection Compound, a larger protein originally identified in human gastric juice, and BPC-157 is a fifteen-amino-acid fragment of that parent compound (Sikiric et al., Life Sciences, 1994). Put plainly, the sequence is a slice taken from a naturally occurring molecule rather than something dreamed up from scratch.

So when research-grade BPC-157 gets described as "synthetic," that's a statement about how it's made, not about where the sequence came from. The lab just reproduces that fifteen-residue stretch directly, building the chain one residue at a time. What you end up with is a defined, single-sequence peptide matching the corresponding fragment of the parent protein. The gastric-juice origin also explains why the molecule was studied as a cytoprotective fragment in the first place (review of BPC-157 as a gastric pentadecapeptide).

Structure and Stability: A Built-In Contradiction

One of the more intriguing things about the BPC-157 chemical structure is an apparent contradiction in how it behaves. On one hand, it looks tough: stable at room temperature, and described in the literature as staying intact in human gastric juice for more than 24 hours - a harsh, acidic, enzyme-rich setting that dismantles most peptides fast. On the other hand, animal-model pharmacokinetic work reports a short elimination half-life, on the order of minutes, once the peptide is in circulation (He et al., Frontiers in Pharmacology, 2022).

How can one molecule be both durable and short-lived? Structure answers the riddle. Resisting breakdown in gastric juice is about surviving one specific set of conditions, and a small, proline-constrained fragment can be a poor target for the particular enzymes at work there. Clearance from the bloodstream is an entirely different process, run by different machinery, and small unstructured peptides tend to get processed and removed quickly. The real lesson is that "stability" is never a single number. It depends on the environment, and a peptide's structure decides how it fares in each one. For a related angle on how chemistry tunes a peptide's persistence, see our explainer on how chemistry changes a peptide's half-life.

A Note on Names: Research Material vs Approved Drugs

One last point belongs with any structural discussion. "BPC-157" works as a research compound name, and it's important not to confuse research-grade material with an approved medicine. Research-grade BPC-157 is a laboratory chemical. It is not equivalent to, nor is it, an FDA-approved pharmaceutical product, and it is not approved by any drug regulatory agency for human use. That distinction is purely about regulatory status, separate from anything in the molecule's chemistry - but it's essential context every time the name comes up.

Frequently Asked Questions

How many amino acids are in BPC-157?

BPC-157 is a pentadecapeptide, meaning it is built from exactly 15 amino acid residues joined in a single chain. The "pentadeca" prefix is Greek for fifteen, and the term is the standard way the research literature refers to the molecule.

What is the amino acid sequence of BPC-157?

The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, read from the N-terminus to the C-terminus. That string of three-letter codes is the molecule's primary structure - the exact order of its 15 building blocks.

What is the molecular formula of BPC-157?

The molecular formula is C₆₂H₉₈N₁₆O₂₂, corresponding to a molar mass of about 1,419.6 g/mol. It also carries standard registry identifiers, including CAS number 137525-51-0 and PubChem CID 9941957, which let researchers look up the exact structure unambiguously.

Is research-grade BPC-157 the same as an FDA-approved drug?

No. Research-grade BPC-157 is a laboratory chemical sold for research use only and is not equivalent to any FDA-approved pharmaceutical. BPC-157 is not approved by any drug regulatory agency for human use.

Conclusion

Strip away the noise and the BPC-157 chemical structure is refreshingly concrete: a defined fifteen-residue peptide, sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, formula C₆₂H₉₈N₁₆O₂₂, with a full set of registry identifiers and a distinctive proline-rich backbone. Structure is the foundation everything else is built on, which makes it the right place to start when researching any compound. To go deeper on the threads raised here, pair this with our pieces on peptide shape and function and peptide half-life - and keep the research-use-only framing front of mind throughout.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.